BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21243541)

  • 1. Inflammatory demyelinating neuropathies.
    Lopate G; Pestronk A
    Curr Treat Options Neurol; 2011 Apr; 13(2):131-42. PubMed ID: 21243541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
    Ueda M; Kusunoki S
    Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré Syndrome.
    van Der Meché FG ; van Doorn PA
    Curr Treat Options Neurol; 2000 Nov; 2(6):507-516. PubMed ID: 11096775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory and paraproteinemic neuropathies.
    Monaco S; Turri E; Zanusso G; Maistrello B
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
    Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
    Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2013 Dec; (12):CD001797. PubMed ID: 24379104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.
    Pollard JD
    Muscle Nerve; 1987; 10(3):214-21. PubMed ID: 3031499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
    Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
    No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial and long-term management of autoimmune neuropathies.
    Koski CL
    CNS Drugs; 2005; 19(12):1033-48. PubMed ID: 16332144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Van Schaik IN; Winer JB; De Haan R; Vermeulen M
    Cochrane Database Syst Rev; 2002; (2):CD001797. PubMed ID: 12076423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2002; (2):CD001798. PubMed ID: 12076424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dys-immune neuropathies.
    Nobile-Orazio E
    J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results.
    Nobile-Orazio E; Terenghi F
    J Neurol; 2005 May; 252 Suppl 1():I7-13. PubMed ID: 15959669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.